These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20490777)

  • 1. Subversion and coercion: the art of redirecting tumor immune surveillance.
    Mumm JB; Oft M
    Curr Top Microbiol Immunol; 2011; 344():25-39. PubMed ID: 20490777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swords into plowshares: IL-23 repurposes tumor immune surveillance.
    Langowski JL; Kastelein RA; Oft M
    Trends Immunol; 2007 May; 28(5):207-12. PubMed ID: 17395538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immune system - how does anti-tumor immunity arise ?].
    Sankawa Y
    Oncol Res Treat; 2014; 37 Suppl 4():2-5. PubMed ID: 25301189
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokine-based transformation of immune surveillance into tumor-promoting inflammation.
    Mumm JB; Oft M
    Oncogene; 2008 Oct; 27(45):5913-9. PubMed ID: 18836472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of T- and B-cell immunity in the pathogenesis of cancer].
    Savchenko AA; Borisov AG; Kudryavtsev IV; Moshev AV
    Vopr Onkol; 2015; 61(6):867-75. PubMed ID: 26995973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th2-mediated anti-tumour immunity: friend or foe?
    Ellyard JI; Simson L; Parish CR
    Tissue Antigens; 2007 Jul; 70(1):1-11. PubMed ID: 17559575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor escape from immune surveillance.
    Costello RT; Gastaut JA; Olive D
    Arch Immunol Ther Exp (Warsz); 1999; 47(2):83-8. PubMed ID: 10202560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10: master switch from tumor-promoting inflammation to antitumor immunity.
    Oft M
    Cancer Immunol Res; 2014 Mar; 2(3):194-9. PubMed ID: 24778315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune system in extreme longevity.
    Sansoni P; Vescovini R; Fagnoni F; Biasini C; Zanni F; Zanlari L; Telera A; Lucchini G; Passeri G; Monti D; Franceschi C; Passeri M
    Exp Gerontol; 2008 Feb; 43(2):61-5. PubMed ID: 17870272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune surveillance of human cancer: if the cytotoxic T-lymphocytes play the music, does the tumoral system call the tune?
    Hamaï A; Benlalam H; Meslin F; Hasmim M; Carré T; Akalay I; Janji B; Berchem G; Noman MZ; Chouaib S
    Tissue Antigens; 2010 Jan; 75(1):1-8. PubMed ID: 20196816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
    Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
    Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic concepts of inflammation and its role in carcinogenesis.
    Maher SG; Reynolds JV
    Recent Results Cancer Res; 2011; 185():1-34. PubMed ID: 21822817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune surveillance: a balance between protumor and antitumor immunity.
    Ostrand-Rosenberg S
    Curr Opin Genet Dev; 2008 Feb; 18(1):11-8. PubMed ID: 18308558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?
    Salih HR; Nüssler V
    Eur J Med Res; 2001 Aug; 6(8):323-32. PubMed ID: 11549514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.
    Hwang I; Nguyen N
    Arch Pharm Res; 2015 Aug; 38(8):1415-33. PubMed ID: 25634101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unresolved inflammation: 'immune tsunami' or erosion of integrity in immune-privileged and immune-responsive tissues and acute and chronic inflammatory diseases or cancer.
    Khatami M
    Expert Opin Biol Ther; 2011 Nov; 11(11):1419-32. PubMed ID: 21663532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and immune surveillance in cancer.
    Chow MT; Möller A; Smyth MJ
    Semin Cancer Biol; 2012 Feb; 22(1):23-32. PubMed ID: 22210181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class I antigens, immune surveillance, and tumor immune escape.
    Garcia-Lora A; Algarra I; Garrido F
    J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.
    Allavena P; Sica A; Garlanda C; Mantovani A
    Immunol Rev; 2008 Apr; 222():155-61. PubMed ID: 18364000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T cell immune surveillance: Phenotypic, functional and migratory heterogeneity for tailored immune responses.
    Zielinski CE
    Immunol Lett; 2017 Oct; 190():125-129. PubMed ID: 28827022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.